Introduction Cutaneous T-cell lymphoma (CTCL) is a malignancy of clonally expanded T-cells that infiltrate the skin.1 The International Consensus Classification (ICC) of Mature Lymphoid Neoplasms and the 5th edition of the World Health Organization Classification of Haematolymphoid Tumours identify nine different clinicopathologic entities under the category of CTCL.2,3 The most common subtype is mycosis fungoides […]
New York, USA, Sept. 06, 2023 (GLOBE NEWSWIRE) — Chronic Refractory Cough Market to Observe Stupendous Growth by 2032, Assesses DelveInsight | Key Players to Watch Out – Merck, Kyorin, NeRRe, Bellus Health, GSK, Axalbion, Aldeyra, Genentech The chronic refractory cough market size shall grow during the forecast period (2023–2032) owing to the launch of […]
Viale PH. The American Cancer Society’s facts & figures: 2020 Edition. J Adv Practitioner Oncol. 2020;11(2):135–6. Google Scholar Wang Z, Guo E, Yang B, Xiao R, Lu F, You L, Chen G. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: cervical, ovarian and uterine cancer. […]
Abstract Understanding the genetic and nongenetic determinants of tumor protein 53 (TP53)–mutation-driven clonal evolution and subsequent transformation is a crucial step toward the design of rational therapeutic strategies. Here we carry out allelic resolution single-cell multi-omic analysis of hematopoietic stem/progenitor cells (HSPCs) from patients with a myeloproliferative neoplasm who transform to TP53-mutant secondary acute myeloid […]
New York, USA, Sept. 04, 2023 (GLOBE NEWSWIRE) — Cervical Dysplasia Market Size and Share to Rise by 2032, Assesses DelveInsight | Key Companies – GlaxoSmithKline, Merck, Frantz Viral, Brooklyn ImmunoTherapeutics, PapiVax, Inovio The cervical dysplasia market is expected to grow significantly owing to an increased screening rate and increasing initiatives to create public awareness. […]
Halpern was an assistant U.S. attorney for more than 30 years. He retired in 2020. He is a member of The San Diego Union-Tribune’s Community Voices Project. Last year, he moved from Mission Hills to Boston for treatment at the Dana-Farber Cancer Institute. Occasionally, life throws you a curve. I certainly felt that way when […]
Aaron T. Gerds, MD, MS The benefits in symptom burden, spleen size, and transfusion dependence demonstrated by treatment momelotinib in patients with myelofibrosis represent a potential key advance for this treatment paradigm, according to Aaron T. Gerds, MD, PhD. A new drug application (NDA) seeking the approval of momelotinib as a potential therapeutic option in […]
